Since considerable time big medicine distribution programs (mainly on HIV and TB) have been enrolled by entities like WHO and the Global Fund.
How is the aspect of Medication Safety covered in these programs? Both policy wise and practically?
Utrecht University student Christiaan van Bommel BSc Pharm, and almost graduated as MSc Pharm, will look into this more deeply.
Results are to be expected by the end of July 2016.